Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 52Breast Neoplasms 24Lung Neoplasms 21Triple Negative Breast Neoplasms 16Neoplasm Metastasis 16Pancreatic Neoplasms 15Neoplasms 15Colorectal Neoplasms 14Stomach Neoplasms 13Head and Neck Neoplasms 12Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 11Uterine Cervical Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Small Cell Lung Carcinoma 9Rectal Neoplasms 8Ovarian Neoplasms 8Leukemia, Myeloid, Acute 8Recurrence 7Nasopharyngeal Carcinoma 7Glioblastoma 5Fallopian Tube Neoplasms 5Cholangiocarcinoma 5Urinary Bladder Neoplasms 4Sarcoma 4Oropharyngeal Neoplasms 4Mouth Neoplasms 4Lymphoma 4Endometrial Neoplasms 4Colonic Neoplasms 4

Interventions

pembrolizumab 44Gemcitabine 23enfortumab vedotin 21Nivolumab 20Cisplatin 17avelumab 16Magnetic Resonance Spectroscopy 15Carboplatin 14atezolizumab 13Specimen Handling 12Docetaxel 11sacituzumab govitecan 9Paclitaxel 8Ipilimumab 8durvalumab 6Mitomycin 5Fluorodeoxyglucose F18 5cabozantinib 4Taxes 4toripalimab 3pemigatinib 3erdafitinib 3X-Rays 3Radiosurgery 3Platinum 3Pemetrexed 3Immunoglobulin G 3CTLA-4 Antigen 3Biopsy 3ALT-803 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × Drug Therapy × 1 year × Clear all
NCT06120374 2025-12-30

Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC

Peking University First Hospital

Recruiting
178 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡